药物相关入院研究的方法学问题:聚焦因果评估的元流行病学综述
该综述审查了13项提供药物相关入院患病率数据的研究,发现药物不良反应的患病率为1.3-10%,而药物相关问题为4.5-41%。因果评估方法差异显著,涉及评估者间一致性报告不一,有医生参与评估的研究患病率较低(3.2-4.5%)。作者建议统一研究方法,明确从医学角度评估药物-问题-入院关系。
要点
- 药物相关入院患病率因定义不同差异大:药物不良反应1.3-10%,药物相关问题4.5-41%。
- 因果评估标准不一:仅1项研究要求很可能因果关系,其余仅要求可能因果关系。
- 有医生参与评估的研究患病率较低(3.2-4.5%),无医生参与为8.8-41%。
核心结论
- 方法学差异是药物相关入院患病率文献不一致的重要原因。
- 建议统一研究方案,明确从医学角度评估药物-问题-入院关系,聚焦药物是可能原因的问题。
研究设计与样本
- 对近期一项荟萃分析中纳入的原始研究进行综述,提取并汇总方法学特征,尤其关注因果评估。
- 共纳入13项提供药物相关入院患病率数据的研究。
主要发现
- 7项研究聚焦药物不良反应,患病率1.3-10%;6项研究采用更宽泛的药物相关问题概念,患病率4.5-41%。
- 13项研究中10项评估了药物与特定问题间的因果关系;仅1项要求很可能因果关系,其余仅要求可能因果关系。
- 8项研究涉及多名评估者,其中3项报告了评估者间一致性,范围从无一致性到几乎完全一致。
- 5项研究有医生参与评估,患病率3.2-4.5%;无医生参与的研究患病率8.8-41%。
临床怎么用
- 临床药师在解读药物相关入院研究时,需注意因果评估标准和评估者构成的差异。
- 建议在相关研究中明确药物-问题-入院关系的医学评估,并优先关注药物是可能原因的问题。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate methodological aspects potentially related to the diverging scientific literature on the prevalence of drug-related hospitalisations, focusing on causality assessments. METHODS: Original studies contributing data to a recent meta-analysis were reviewed. Methodological aspects, in particular those related to causality assessments, were extracted and compiled. RESULTS: Thirteen studies provided data on the prevalence of drug-related admissions. Seven studies focused on adverse drug reactions (prevalences 1.3-10%), and six studies used the broader concept of drug-related problems (prevalences 4.5-41%). In 10 out of 13 studies, causality between the drug and the specified problem was assessed. One study required a probable causal relationship; the remaining studies merely required a possible causal relationship. Five studies assessed the association between the problem assumed to be related to drug therapy and the admission, at one end requiring the former to be demonstrated as the underlying cause and, at the other, merely requiring a temporal relationship between drug intake and admission. Three out of eight studies involving multiple assessors for all/some cases reported the inter-rater agreement, ranging from none to almost perfect. Physicians were involved in the assessments in five studies, reporting prevalences of 3.2% to 4.5%, while studies without such medical input reported prevalences of 8.8% to 41%. CONCLUSIONS: This review illustrates that methodological issues contribute to the diverse literature on drug-related admissions. We provide suggestions for harmonisation of research, including explicitly assessing the drug-problem-admission relationships from a medical perspective, focusing on problems where the drug treatment is the probable culprit.
引用
- Wallerstedt SM, Hoffmann M, Lönnbro J, et al. Methodological issues in research on drug-related admissions: A meta-epidemiological review with focus on causality assessments. Br J Clin Pharmacol. 2021. PMID: 34327734. doi:10.1111/bcp.15012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。